BOSTON and CAMBRIDGE, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Dewpoint Therapeutics and ConcertAI announced the first phase of their Translational Oncology partnership, aligned around Dewpoint’s ...

The editor’s pick for this issue is a review article discussing the promise of hyperpolarised xenon MRI, a non-invasive ...

The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...

Executives at a local company believe they have a quicker and less expensive path to get their new drug approved.

Creating contingency plans against geopolitical uncertainty was a key theme at the 2024 Outsourcing in Clinical Trials and ...

A novel study from Korea uncovers the process of synthesis and pivotal role of the transfer RNA-derived fragment, ...

A new review published in Blood Cancer Discovery outlines a major multiple myeloma research project that supported a key ...

Discover the critical shortage of physician-scientists, funding, and mentorship in pediatric research and its potential impact on patient care.

NeuroSigma, Inc., a Los Angeles-based bioelectronics company, announced today that the Center for Evidence-Based Psychiatry ...

Missing and incomplete data can cause headaches for clinical trial operators; new innovations are providing an antidote.

Over the past two decades, awareness has grown about the wide-ranging applications of genomic technologies in human health and beyond.1 This awareness was further heightened during the coronavirus ...

Josh Jennings, an analyst from TD Cowen, maintained the Buy rating on TransMedics Group (TMDX – Research Report). The associated price target ...